Cargando…
Hypercalcemia of malignancy and new treatment options
Hypercalcemia of malignancy affects up to one in five cancer patients during the course of their disease. It is associated with both liquid malignancies, commonly multiple myeloma, leukemia, and non-Hodgkins lymphoma and solid cancers, particularly breast and renal carcinomas as well as squamous cel...
Autores principales: | Sternlicht, Hillel, Glezerman, Ilya G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675637/ https://www.ncbi.nlm.nih.gov/pubmed/26675713 http://dx.doi.org/10.2147/TCRM.S83681 |
Ejemplares similares
-
Denosumab for Patients With Persistent or Relapsed Hypercalcemia of
Malignancy Despite Recent Bisphosphonate Treatment
por: Hu, Mimi I., et al.
Publicado: (2013) -
Hypercalcemia of Malignancy
por: Malangone, Steve, et al.
Publicado: (2015) -
Hypercalcemia of Malignancy
por: Feldenzer, Kaitlin L., et al.
Publicado: (2018) -
Hypercalcemia in Urological Malignancies: A Review
por: Aggarwal, Gaurav, et al.
Publicado: (2022) -
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift
por: O’Callaghan, Sondra, et al.
Publicado: (2020)